Loading...

Pamela Coxson

Title(s)Specialist, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone628-206-8038
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Projected impact of a reduction in sugar-sweetened beverage consumption on diabetes and cardiovascular disease in Argentina: A modeling study. PLoS Med. 2020 07; 17(7):e1003224. Salgado MV, Penko J, Fernandez A, Konfino J, Coxson PG, Bibbins-Domingo K, Mejia R. PMID: 32722677.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Cardiovascular and diabetes burden attributable to physical inactivity in Mexico. Cardiovasc Diabetol. 2020 Jun 29; 19(1):99. Medina C, Coxson P, Penko J, Janssen I, Bautista-Arredondo S, Barquera S, Bibbins-Domingo K. PMID: 32600339.
      View in: PubMed   Mentions:    Fields:    
    3. Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults. JAMA Cardiol. 2020 May 27. Hamad R, Penko J, Kazi DS, Coxson P, Guzman D, Wei PC, Mason A, Wang EA, Goldman L, Fiscella K, Bibbins-Domingo K. PMID: 32459344.
      View in: PubMed   Mentions: 2     Fields:    
    4. The Cardiovascular Health Burdens of Solitary Confinement. J Gen Intern Med. 2019 10; 34(10):1977-1980. Williams BA, Li A, Ahalt C, Coxson P, Kahn JG, Bibbins-Domingo K. PMID: 31228050.
      View in: PubMed   Mentions:    Fields:    
    5. Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina. Medicina (B Aires). 2019; 79(6):438-444. Salgado MV, Coxson P, Konfino J, Penko J, Irazola VE, Gutiérrez L, Fernández A, Mejía R. PMID: 31829945.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial. Ann Intern Med. 2019 02 19; 170(4):221-229. Kazi DS, Penko J, Coxson PG, Guzman D, Wei PC, Bibbins-Domingo K. PMID: 30597485.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Effect of Money-Back Guarantees on the Cost-Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors. Ann Intern Med. 2018 06 19; 168(12):896-898. Kazi DS, Penko J, Ollendorf DA, Coxson PG, Bibbins-Domingo K. PMID: 29610832.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China. Circulation. 2017 Oct 24; 136(17):1575-1584. Huang C, Moran AE, Coxson PG, Yang X, Liu F, Cao J, Chen K, Wang M, He J, Goldman L, Zhao D, Kinney PL, Gu D. PMID: 28882886.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    9. Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial. JAMA. 2017 08 22; 318(8):748-750. Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, Bibbins-Domingo K. PMID: 28829863.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    10. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke. Circulation. 2017 Sep 19; 136(12):1087-1098. Heller DJ, Coxson PG, Penko J, Pletcher MJ, Goldman L, Odden MC, Kazi DS, Bibbins-Domingo K. PMID: 28687710.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    11. Comparing Strategies for Lipid Lowering in Argentina: An Analysis from the CVD Policy Model-Argentina. J Gen Intern Med. 2017 May; 32(5):524-533. Konfino J, Fernandez A, Penko J, Mason A, Martinez E, Coxson P, Heller D, Moran A, Bibbins-Domingo K, Pérez-Stable EJ, Mejía R. PMID: 27853916.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    12. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study. PLoS Med. 2016 Nov; 13(11):e1002158. Sánchez-Romero LM, Penko J, Coxson PG, Fernández A, Mason A, Moran AE, Ávila-Burgos L, Odden M, Barquera S, Bibbins-Domingo K. PMID: 27802278.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    13. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease. JAMA. 2016 Aug 16; 316(7):743-53. Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K. PMID: 27533159.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    14. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model. Hypertension. 2016 07; 68(1):88-96. Moise N, Huang C, Rodgers A, Kohli-Lynch CN, Tzong KY, Coxson PG, Bibbins-Domingo K, Goldman L, Moran AE. PMID: 27181996.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    15. Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study. Am J Hypertens. 2016 10; 29(10):1195-205. Vasudeva E, Moise N, Huang C, Mason A, Penko J, Goldman L, Coxson PG, Bibbins-Domingo K, Moran AE. PMID: 27172970.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study. J Am Geriatr Soc. 2016 05; 64(5):1015-23. Odden MC, Moran AE, Coxson PG, Peralta CA, Goldman L, Bibbins-Domingo K. PMID: 27225357.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    17. Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study. PLoS One. 2016; 11(2):e0146820. Wang M, Moran AE, Liu J, Coxson PG, Penko J, Goldman L, Bibbins-Domingo K, Zhao D. PMID: 26840409.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study. PLoS Med. 2015 Aug; 12(8):e1001860. Gu D, He J, Coxson PG, Rasmussen PW, Huang C, Thanataveerat A, Tzong KY, Xiong J, Wang M, Zhao D, Goldman L, Moran AE. PMID: 26241895.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    19. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med. 2015 Apr 21; 162(8):533-41. Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D, Goldman L, Bibbins-Domingo K. PMID: 25894023.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    20. Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model. J Gen Intern Med. 2015 Aug; 30(8):1147-55. Fontil V, Bibbins-Domingo K, Kazi DS, Sidney S, Coxson PG, Khanna R, Victor RG, Pletcher MJ. PMID: 25749880.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015 Jan 29; 372(5):447-55. Moran AE, Odden MC, Thanataveerat A, Tzong KY, Rasmussen PW, Guzman D, Williams L, Bibbins-Domingo K, Coxson PG, Goldman L. PMID: 25629742.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansPHPublic Health
    22. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):78-85. Wang M, Moran AE, Liu J, Coxson PG, Heidenreich PA, Gu D, He J, Goldman L, Zhao D. PMID: 24425706.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    23. Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model. PLoS One. 2013; 8(12):e81723. Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K. PMID: 24349119.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    24. Projected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina. PLoS One. 2013; 8(9):e73824. Konfino J, Mekonnen TA, Coxson PG, Ferrante D, Bibbins-Domingo K. PMID: 24040085.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Response to mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension. 2013 Jun; 61(6):e60. Coxson PG, Bibbins-Domingo K, Cook NR, Joffres M, Schmidt SM. PMID: 23819150.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension. 2013 Mar; 61(3):564-70. Coxson PG, Cook NR, Joffres M, Hong Y, Orenstein D, Schmidt SM, Bibbins-Domingo K. PMID: 23399718.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    27. Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law. Tob Control. 2014 Mar; 23(2):e6. Konfino J, Ferrante D, Mejia R, Coxson P, Moran A, Goldman L, Pérez-Stable EJ. PMID: 23092886.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    28. [The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina]. Rev Panam Salud Publica. 2012 Oct; 32(4):274-80. Ferrante D, Konfino J, Mejía R, Coxson P, Moran A, Goldman L, Pérez-Stable EJ. PMID: 23299288.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Projected impact of urbanization on cardiovascular disease in China. Int J Public Health. 2012 Oct; 57(5):849-54. Chan F, Adamo S, Coxson P, Goldman L, Gu D, Zhao D, Chen CS, He J, Mara V, Moran A. PMID: 22918518.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes. Health Aff (Millwood). 2012 Jan; 31(1):199-207. Wang YC, Coxson P, Shen YM, Goldman L, Bibbins-Domingo K. PMID: 22232111.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    31. Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Circulation. 2012 Jan 17; 125(2):260-70. Galper BZ, Moran A, Coxson PG, Pletcher MJ, Heidenreich P, Lazar LD, Rodondi N, Wang YC, Goldman L. PMID: 22144567.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    32. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011 Sep; 124(9):827-33.e5. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. PMID: 21722862.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    33. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation. 2011 Jul 12; 124(2):146-53. Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L. PMID: 21709063.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    34. Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model. Int J Cardiol. 2011 Aug 04; 150(3):332-7. Moran A, Degennaro V, Ferrante D, Coxson PG, Palmas W, Mejia R, Perez-Stable EJ, Goldman L. PMID: 21550675.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011 Feb 28; 171(4):342-50. Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, Knowles P, Storm JS, Adhikari E, Bibbins-Domingo K, Coxson PG, Pletcher MJ, Hannan P, Haley RW. PMID: 20975012.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    36. Does age modify effectiveness of statin therapy in coronary artery disease? Ann Intern Med. 2010 Jun 15; 152(12):825; author reply 825-6. Pletcher MJ, Coxson PG. PMID: 20547915.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    37. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):243-52. Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, He J, Goldman L. PMID: 20442213.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    38. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18; 362(7):590-9. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. PMID: 20089957.
      View in: PubMed   Mentions: 284     Fields:    Translation:Humans
    39. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health. 2009 Dec; 99(12):2230-7. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. PMID: 19833999.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    40. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009 Feb 17; 150(4):243-54. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. PMID: 19221376.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansPHPublic Health
    41. Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med. 2009 Jan; 36(1):13-20. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. PMID: 19095162.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    42. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. BMC Public Health. 2008 Nov 27; 8:394. Moran A, Zhao D, Gu D, Coxson P, Chen CS, Cheng J, Liu J, He J, Goldman L. PMID: 19036167.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    43. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007 Dec 06; 357(23):2371-9. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. PMID: 18057339.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    44. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002 Jun 06; 346(23):1800-6. Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L. PMID: 12050341.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    Pamela's Networks
    Concepts (158)
    Derived automatically from this person's publications.
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _